Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sanofi
Biotech
HHS cancels mRNA vaccine development funded by BARDA
The decision affects 22 projects valued at around $500 million collectively, and no new mRNA projects will be started.
Darren Incorvaia
Aug 5, 2025 7:20pm
HMNC recalibrates precision depression push after phase 2b miss
Aug 5, 2025 10:38am
Big Pharma-backed program seeks future beyond animal testing
Aug 1, 2025 5:00pm
Sanofi pens $395M China pact for Arrowhead metabolic med
Aug 1, 2025 7:21am
MapLight raises $373M to plot phase 2 journey for Cobenfy rival
Jul 28, 2025 10:23am
Sanofi inks $1.15B buyout to boost RSV pipeline
Jul 22, 2025 4:20am
